A low-protein diet improves insulin sensitivity of endogenous glucose production in predialytic uremic patients

American Journal of Clinical Nutrition

Volumn 65, Issue 5, 1997, Pages 1512-1516

  Rigalleau, Vincent ^a   Blanchetier, Valerie ^b   Combe, Christian ^b   Guillot, Christel ^b   Deleris, Gerard ^b   Aubertin, Jean ^b   Aparicio, Michel ^b   Gin, Henri ^b  

^a HAUT LÉVÊQUE HOSPITAL   (France)

^b NONE

Author keywords

Chronic renal failure; endogenous glucose production; humans; insulin resistance; low protein supplemented diet

Indexed keywords

GLUCOSE; INSULIN;

ADULT; ARTICLE; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GLUCONEOGENESIS; GLUCOSE HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; PROTEIN RESTRICTION; UREMIA;

EID: 0030944242     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/65.5.1512     Document Type: Article

References (30)

1. Emmanouel DS, Lindheimer MD, Katz A. Endocrine function. In: Eknoyan G, Knochel JP, eds. The systemic consequences of renal failure. New York: Grune & Stratton, 1984:177-232.
2. De Fronzo RA, Alvestrand A, Smith D, et al. Insulin resistance in uremia. J Clin Invest 1981;67:563-8.
3. Eidemak I, Feldt-Rasmussen B, Kanstrup IL, et al. Insulin resistance and hyperinsulinemia in mild to moderate progressive renal failure and its association with aerobic work capacity. Diabetologia 1995;38:565-72.
4. Gin H, Aparicio M, Potaux L, et al. Low protein and low phosphorus diet in patients with chronic renal failure: influence on glucose tolerance and tissue insulin sensitivity. Metabolism 1987;36:1080-5.
5. Ma KW, Greene EL, Raij L. Cardiovascular risk factors in chronic renal failure and hemodialysis patients. Am J Kidney Dis 1992;19:505-13.
6. De Fronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979;237:E214-23.
7. Gin H, Combe C, Rigalleau V, et al. Effect of a low-protein, low-phosphorus diet on metabolic insulin clearance in patients with chronic renal failure. Am J Clin Nutr 1994;59:663-6.
8. Schmitz O. Peripheral and hepatic resistance to insulin and hepatic resistance to glucagon in chronic renal failure. Acta Endocrinol 1988;118:125-34.
9. Combe C, Deforges-Lasseur C, Caix J, et al. Compliance and effects of treatment on progression and metabolic disorders of chronic renal failure. Nephrol Dial Transplant 1993;8:412-8.
10. Reaich D, Graham KA, Channon SM, et al. Insulin-mediated changes in PD and glucose uptake after correction of acidosis in humans with CRF. Am J Physiol 1995;268:E121-6.
11. Rizza RA, Mandarino LJ, Gerich JE. Dose-response characteristics for effects of insulin on production and utilization of glucose in man. Am J Physiol 1981;240:E630-9.
12. Bergmeyer HV. Methods of enzymatic analysis. New York: Academic, 1974.
13. Bier DM, Arnold KJ, Sherwan WR, et al. In vivo measurement of glucose and alanine metabolism with stable isotope tracers. Diabetes 1977;26:22-7.
14. Ykï-Järvinen H. Acute and chronic effects of hyperglycemia on glucose metabolism. Diabetologia 1990;33:579-85.
15. Rubenfeld S, Garber AJ. Abnormal carbohydrate metabolism in chronic renal failure: the potential role of accelerated glucose production, increased gluconeogenesis, and impaired glucose disposal. J Clin Invest 1978;62:20-8.
16. Katz J, Rostami H, Dunn A. Evaluation of glucose turnover, body mass and recycling with reversible and irreversible tracers. Biochem J 1974;142:161-70.
17. Levy JC, Brown G, Matthews DR, et al. Hepatic glucose output in humans measured with labelled glucose to reduce negative errors. Am J Physiol 1989;257:E531-40.
18. Ykï-Järvinen H, Consoli A, Nurjhan N, et al. Mechanism for underestimation of isotopically determined glucose disposal. Diabetes 1989;38:744-51.
19. Friedman JE, Lynis Dohm G, Elton CW, et al. Muscle insulin resistance in uremic humans: glucose transport, glucose transporters, and insulin receptors. Am J Physiol 1991;261:E87-94.
20. Castellino P, Solini A, Luzi L, et al. Glucose and amino acid metabolism in chronic renal failure: effect of insulin and amino acid. Am J Physiol 1992;262:F168-76.
21. De Fronzo RA. The triumvirate: β-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes 1988;37:667-87.
22. Lillioja S, Mott DM, Zawadski JK, et al. Glucose storage is a major determinant of in vivo "insulin resistance" in subjects with normal glucose tolerance. J Clin Endocrinol Metab 1986;62:922-7.
23. Imai E, Yamauchi A, Noguchi T, et al. Effects of chronic renal failure on the regulation of pyruvate kinase. Metabolism 1987;36:601-6.
24. Graf H, Prager R, Kovarik J, et al. Glucose metabolism and insulin sensitivity in patients on chronic hemodialysis. Metabolism 1985;34:974-7.
25. McCaleb ML, Izzo MS, Lockwood DH. Characterization and partial purification of a factor from uremic human serum that induces insulin resistance. J Clin Invest 1985;75:391-6.
26. Larriviere F, Chiasson JL, Schiffrin A, et al. Effects of dietary protein restriction on glucose and insulin metabolism in normal and diabetic humans. Metabolism 1994;43:462-7.
27. Combe C, Morel D, De Précigout V, et al. Long-term control of hyperparathyroidism in advanced renal failure by low-phosphorus low-protein diet supplemented with calcium (without changes in plasma calcitriol). Nephron 1995;70:287-95.
28. Akmal M, Massry SG, Goldstein DA, et al. Role of parathyroid hormone in the glucose intolerance of chronic renal failure. J Clin Invest 1985;75:1037-44.
29. Harter HR, Santiago JV, Rutherford WE, et al. The relative role of calcium, phosphorus and parathyroid hormone in glucose- and tolbutamide-mediated insulin release. J Clin Invest 1976;58:359-67.
30. Vuorinen-Markkola H, Ykï-Järvinen H. Hyperuricemia and insulin resistance. J Clin Endocrinol Metab 1994;78:25-9.